tiprankstipranks
Trending News
More News >
Collegium Pharmaceutical (COLL)
NASDAQ:COLL
US Market

Collegium Pharmaceutical (COLL) Income Statement

Compare
473 Followers

Collegium Pharmaceutical Income Statement

Last quarter (Q4 2024), Collegium Pharmaceutical's total revenue was $181.95M, an increase of 21.51% from the same quarter last year. In Q4, Collegium Pharmaceutical's net income was $12.54M. See Collegium Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 631.45M$ 566.77M$ 463.93M$ 276.87M$ 310.02M
Gross Profit
$ 377.34M$ 326.17M$ 209.49M$ 150.62M$ 179.84M
Operating Expenses
$ 207.45M$ 150.71M$ 176.17M$ 128.41M$ 123.60M
Depreciation and Amortization
$ 0.00$ 149.26M$ 134.39M$ 68.94M$ 61.61M
EBITDA
$ 169.90M$ 308.33M$ 168.76M$ 86.58M$ 118.07M
Operating Income
$ 169.90M$ 166.96M$ -104.57M$ -46.70M$ -5.09M
Other Income/Expenses
$ -71.33M$ -91.23M$ -62.17M$ -21.00M$ -28.65M
Pretax Income
$ 98.57M$ 75.73M$ -28.85M$ -3.37M$ 27.58M
Net Income
$ 69.19M$ 48.16M$ -25.00M$ 71.52M$ 26.75M
Per Share Metrics
Basic EPS
$ 2.14$ 1.60$ -0.74$ 2.05$ 0.78
Diluted EPS
$ 1.71$ 1.29$ -0.74$ 1.86$ 0.76
Weighted Average Shares Outstanding
32.27M 33.74M 33.83M 34.94M 34.41M
Weighted Average Shares Outstanding (Diluted)
40.42M 41.79M 33.83M 41.05M 35.15M
Currency in USD

Collegium Pharmaceutical Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis